Lexeo partners with Johnson & Johnson on cardiac gene therapy delivery
Go back to Lexeo partners with Johnson & Johnson on cardiac gene therapy delivery| Johnson & Johnson (NYSE: JNJ) | Delayed: 263.40 +4.13 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $259.27 | 52 Week High | $126.07 | |||
| Open | $261.43 | 52 Week Low | $94.28 | |||
| Day High | $263.71 | P/E | 54.76 | |||
| Day Low | $259.61 | EPS | $4.81 | |||
| Volume | 6,351,046 | |||||
| (NASDAQ: LXEO) | Delayed: 4.66 -0.05 (1.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.71 | 52 Week High | $ | |||
| Open | $4.72 | 52 Week Low | $ | |||
| Day High | $4.90 | P/E | N/A | |||
| Day Low | $4.50 | EPS | $ | |||
| Volume | 656,870 | |||||

